Back to search

Article

Distinct cerebrospinal fluid DNA methylation signatures linked to Alzheimer’s disease

2025-04-07

Abstract excerpt

Alzheimer’s disease (AD) accounts for more than 60% of the dementia cases and currently there is no curative treatment for it. With the emergence of potentially disease modifying treatments, early diagnosis is key to identify patient groups that would benefit from such treatments, aiming to prevent severe cognitive decline. We previously identified a set of DNA methylation signatures that allow for accurate diagno...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c6a04b3d-810b-5cdf-aa02-45ebbac3b914
DOI
10.1101/2025.04.03.647115
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Distinct cerebrospinal fluid DNA methylation signatures linked to Alzheimer’s diseaseDOI 10.1101/2025.04.03.647115
Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjectsSemantic proximity
Towards a Personalized Medicine through Liquid Biopsy in Alzheimer’s disease: Epigenome of cell-free DNA reveals methylation differences linked to APOE statusSemantic proximity
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjectsSemantic proximity
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.Semantic proximity
DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-typesSemantic proximity
Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late‐onset dementia due to Alzheimer's diseaseSemantic proximity
Exploring novel blood-based DNA methylation biomarkers for alzheimer's disease via targeted sequencing of highly variable CpG sites.Semantic proximity
A comprehensive study on epigenetic biomarkers in early detection and prognosis of Alzheimer's diseaseSemantic proximity
Distinctive cell-free DNA methylation characterizes presymptomatic genetic frontotemporal dementia.Semantic proximity
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive statusSemantic proximity
Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer’s disease identifies cognitive statusSemantic proximity
Early epigenetic changes of Alzheimer’s disease in the human hippocampusSemantic proximity
Select a neighboring publication to make it the new centre.